Abeona Therapeutics Inc (NASDAQ:ABEO) price on Friday, March 21, rose 0.19% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $5.15.
A look at the stock’s price movement, the close in the last trading session was $5.14, moving within a range at $5.085 and $5.35. Turning to its 52-week performance, $8.45 and $3.05 were the 52-week high and 52-week low respectively. Overall, ABEO moved -11.51% over the past month.
Abeona Therapeutics Inc’s market cap currently stands at around $223.87 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-19.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ABEO is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend ABEO as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ABEO’s current price about -1.87% and -5.50% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 43.04, while 7-day volatility ratio is 5.26% and 5.68% in the 30-day chart. Further, Abeona Therapeutics Inc (ABEO) has a beta value of 1.68, and an average true range (ATR) of 0.28. Analysts have given the company’s stock an average 52-week price target of $16, forecast between a low of $16 and high of $16. Looking at the price targets, the low is -210.68% off current price level while to achieve the yearly target high, price needs to move -210.68%. Nonetheless, investors will most likely welcome a -210.68% jump to $16 which is the analysts’ median price.
If we refocus on Abeona Therapeutics Inc (NASDAQ:ABEO), historical trading data shows that trading volumes averaged 0.44 over the past 10 days and 307.08K over the past 3 months. The company’s latest data on shares outstanding shows there are 45.64 million shares.
The 11.70% of Abeona Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 71.71% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 2.52 million on 2025-02-28, giving us a short ratio of 9.7. The data shows that as of 2025-02-28 short interest in Abeona Therapeutics Inc (ABEO) stood at 611.00002 of shares outstanding, with shares short rising to 2.48 million registered in 2025-01-31. Current price change has pushed the stock -7.54% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ABEO stock continues to rise going into the next quarter.
